According to Newsweek magazine's 2024 ranking, the CHUV is one of Switzerland's top five university hospitals and one of the best in the world. Thanks to its collaboration with the Faculty of Biology and Medicine at the University of Lausanne, the CHUV plays a leading role on a European scale in medical care, medical research, and education.
CHUV – Centre hospitalier universitaire vaudoise
What is the role of CHUV in Autopix
The CHUV is the leader for work package 3, “Self-performed and point-of-care imaging”, and will sponsor the PiX-Risk and PiX-Monitor trials.
Q&A
In what part of the patient journey will your institution most likely contribute?
The CHUV will mainly contribute to the monitoring of at-risk arthritis patients and the therapeutic monitoring of established RA and PSA patients with our remote monitoring platform Detectra. Additionally, we will be involved in the diagnosis and prediction of established arthritis via work package 4.
What long-term impacts do you envision of your contribution?
We envision that arthritis and disease flares can be detected earlier through the use of non-invasive imaging biomarkers, and therefore, patient care will improve. However, with better remote monitoring, rheumatologists will be able to see patients at the right time and will gain time for patients with active disease by remote monitoring of those who are doing well.
Why is it so important?
Worldwide, we face a shortage of rheumatologists and health professionals in general. Patients also need to wait between 3 and 6 months for an appointment, which is unacceptably long.
Contact
Prof. Thomas Hügle
Professor and Head of Rheumatology
Dr. Marc Blanchard
Project manager Detectra
Cinja Koller
Doctoral candidate